Use of remdesivir for COVID-19 in patients with hematologic cancer

PURPOSES: Patients with hematologic malignancies (HM) are among the individuals with highest risk of COVID-19 complications. We report the impact of remdesivir in patients with hematologic malignancies (HM) during Omicron in Mexico City. METHODS: All patients with HM and COVID-19 during December 202...

Descripción completa

Detalles Bibliográficos
Autores principales: Martin-Onraët, Alexandra, Barrientos-Flores, Corazón, Vilar-Compte, Diana, Pérez-Jimenez, Carolina, Alatorre-Fernandez, Pamela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9744041/
https://www.ncbi.nlm.nih.gov/pubmed/36508048
http://dx.doi.org/10.1007/s10238-022-00964-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9744041/
https://www.ncbi.nlm.nih.gov/pubmed/36508048
http://dx.doi.org/10.1007/s10238-022-00964-4

Ejemplares similares